Tom Loughman
Technik-/Wissenschafts-/F&E-Leiter bei ITERUM THERAPEUTICS PLC
Ursprung des Netzwerks ersten Grades von Tom Loughman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tom Loughman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| DURATA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Chief Executive Officer Corporate Secretary Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics International Ltd. engages in the development of clinical-stage pharmaceutical products. The company was founded in 2015 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Iterum Therapeutics US Holding Ltd. operates as a clinical-stage pharmaceutical company. The company was founded in 2018 and is headquartered in Chicago, IL. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director/Board Member President General Counsel Director of Finance/CFO | |
| University of Illinois At Urbana–Champaign | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Iterum Therapeutics Bermuda Ltd.
 Iterum Therapeutics Bermuda Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics Bermuda Ltd. is an emerging growth company, which engages in the provision of financing activities. The company was founded on November 6, 2019 and is headquartered in Hamilton, Bermuda. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Informed Medical Communications, Inc.
 Informed Medical Communications, Inc. Miscellaneous Commercial ServicesCommercial Services Informed Medical Communications, Inc. provides medical forums, training services, and integrated medical communications. It is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The firm offers a communications training service for elite skill development for sales organizations and speaker bureaus. The company was founded in 2005 and is headquartered in Edison, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| HARPOON THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
| RALLYBIO CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Iterum Therapeutics US Ltd.
 Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Iterum Therapeutics US Ltd. manufactures pharmaceutical products. The company was founded in 2015 and is headquartered in Chicago, IL. | Pharmaceuticals: Major | Chief Executive Officer President | |
Iterum Pharmaceuticals LLC
 Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iterum Pharmaceuticals LLC manufactures pharmaceutical products. The company is headquartered in Chicago, IL. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Chief Executive Officer General Counsel | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Kellogg School of Management | College/University | Graduate Degree Graduate Degree | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NIOX GROUP PLC | Medical/Nursing Services | Director/Board Member | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member | |
| 3G Advisors LLC | Corporate Officer/Principal | ||
| ACUTUS MEDICAL, INC. | Medical Specialties | Director/Board Member | |
| ARAVIVE, INC. | Biotechnology | Director/Board Member | |
MQ: Transforming Mental Health
 MQ: Transforming Mental Health Miscellaneous Commercial ServicesCommercial Services MQ: Transforming Mental Health is a British company that focuses on driving mental health research to better understand, diagnose, and treat mental illness. The non-profit company is based in London, UK. The company brings people and researchers together to make groundbreaking progress in this field. The company advocates for transforming mental health and is supported by a scientific network. The company is honing their focus on the areas that are most vital and can have the greatest impact on the mental health landscape. | Miscellaneous Commercial Services | Chairman | |
Nalu Medical, Inc.
 Nalu Medical, Inc. Medical SpecialtiesHealth Technology Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA. | Medical Specialties | Director/Board Member | |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Private Equity Investor | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| AXONICS, INC. | Medical Specialties | Director/Board Member | |
| University of Saskatchewan | College/University | Doctorate Degree | |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | President | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Director/Board Member | |
| Life Cycle Pharma A/S | Chairman | ||
Oculis SA
 Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 39 |
| Vereinigtes Königreich | 5 |
| Irland | 3 |
| Bermuda | 2 |
| Norwegen | 2 |
Sektoral
| Health Technology | 35 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Finance | 3 |
| Retail Trade | 2 |
Operativ
| Director/Board Member | 201 |
| Independent Dir/Board Member | 67 |
| Corporate Officer/Principal | 58 |
| Chairman | 19 |
| Undergraduate Degree | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Healy | 50 |
| Patrick Heron | 42 |
| Brent Ahrens | 30 |
| Ron Hunt | 29 |
| Paul Edick | 27 |
| Mark Chin | 25 |
| Mohammed Malik | 24 |
| Robert Hopfner | 20 |
| Beth Hecht | 16 |
| Corey Fishman | 15 |
| Michael Dunne | 14 |
| David Kelly | 14 |
| Judith Matthews | 10 |
| Sailaja Puttagunta | 7 |
| Benjamin M. Pe | 6 |
- Börse
- Insiders
- Tom Loughman
- Unternehmensverbindungen
